Nasacort and Narcolepsy - a phase IV clinical study of FDA data

Summary:

Narcolepsy is reported as a side effect among people who take Nasacort (triamcinolone acetonide), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Xyrem, and have Cataplexy.

The phase IV clinical study analyzes which people have Narcolepsy when taking Nasacort. It is created by eHealthMe based on reports of 12,923 people who have side effects when taking Nasacort from the FDA, and is updated regularly.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

What is Narcolepsy?

Narcolepsy (brain's inability to regulate sleep-wake cycles normally) is found to be associated with 430 drugs and 738 conditions by eHealthMe. Check the latest studies of Narcolepsy.

On Jul, 12, 2026

12,923 people reported to have side effects when taking Nasacort.
Among them, 12 people (0.09%) have Narcolepsy.

Among these 12 people:

How long have people been on Nasacort when they have Narcolepsy? *

What is the gender of people who have Narcolepsy when taking Nasacort? *

female: 50 %
male: 50 %

What is the age of people who have Narcolepsy when taking Nasacort? *

What are other drugs people take besides Nasacort? *

What are other side effects people have besides Narcolepsy? *

Nightmares (unpleasant dreams): 5 people, 41.67%
Stress And Anxiety: 5 people, 41.67%
Pain: 5 people, 41.67%
Osteomyelitis (infection of bone): 5 people, 41.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 41.67%
Cellulitis (infection under the skin): 5 people, 41.67%
Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 33.33%
Blood Sodium Increased: 2 people, 16.67%
Plague: 2 people, 16.67%
Overdose: 2 people, 16.67%

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 66.67%
Drowsiness: 3 people, 25.00%
Pain: 3 people, 25.00%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 16.67%
Migraine (headache): 2 people, 16.67%
Headache (pain in head): 2 people, 16.67%
Sleep Disorder: 2 people, 16.67%
Thyroid Diseases: 1 person, 8.33%
Asthma: 1 person, 8.33%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort and have Narcolepsy?

- Check whether Narcolepsy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasacort:

Nasacort (13,298 reports)

Narcolepsy treatments and more:

Narcolepsy (79,888 reports)

Browse all side effects of Nasacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Narcolepsy:

Narcolepsy (430 drugs)

Browse all the conditions that are associated with Narcolepsy:

Narcolepsy (738 conditions)

Related publications that referenced our studies

Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Nasacort) and Nasacort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.